St. Joseph Healthcare is a network of hospitals and health care facilities in the greater Nashua area, southern New Hampshire and northern Massachusetts. The main facility is the 208-bed St. Joseph Hospital, with satellite centers in Milford and Merrimack. The service is now part of Covenant Health Systems.

There are 208 beds in Saint Joseph Hospital.

During the past decade, Saint Joseph Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Dartmouth-Hitchcock Medical Center" with 2 trials sponsored, "CairnSurgical, Inc." with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Hospital" are "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials), "Breast Adenocarcinoma" (3 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials) and "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "Saint Joseph Hospital" in a lesser frequency.

Most popular intervention types in "Saint Joseph Hospital" are "Other" (17 trials), "Drug" (15 trials), "Biological" (7 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Paclitaxel" (5 trials), "Quality-of-Life Assessment" (5 trials), "Carboplatin" (4 trials) and "Questionnaire Administration" (4 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Hospital" are 17 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph Hospital". undefined are not yet recruiting, 4 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Saint Joseph Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

Saint Joseph Hospital has several departments that took part in Clinical trials: "Oncology Center at St. Joseph Hospital" - 6 trials